Advanced company searchLink opens in new window

BELLICUM PHARMA LIMITED

Company number 10415132

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
18 Jul 2023 GAZ2 Final Gazette dissolved following liquidation
18 Apr 2023 LIQ13 Return of final meeting in a members' voluntary winding up
04 Aug 2022 LIQ01 Declaration of solvency
25 Jul 2022 600 Appointment of a voluntary liquidator
25 Jul 2022 RESOLUTIONS Resolutions
  • LRESSP ‐ Special resolution to wind up on 2022-07-12
14 Jun 2022 DISS16(SOAS) Compulsory strike-off action has been suspended
14 Jun 2022 GAZ1 First Gazette notice for compulsory strike-off
09 Dec 2021 SH19 Statement of capital on 9 December 2021
  • GBP 1
09 Dec 2021 RESOLUTIONS Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
09 Dec 2021 CAP-SS Solvency Statement dated 07/12/21
09 Dec 2021 SH20 Statement by Directors
08 Dec 2021 SH01 Statement of capital following an allotment of shares on 7 December 2021
  • GBP 988,345
08 Oct 2021 CS01 Confirmation statement made on 6 October 2021 with no updates
08 Oct 2021 PSC05 Change of details for Bellicum Pharmaceuticals, Inc. as a person with significant control on 7 October 2021
13 Apr 2021 DISS40 Compulsory strike-off action has been discontinued
06 Apr 2021 GAZ1 First Gazette notice for compulsory strike-off
27 Nov 2020 SH20 Statement by Directors
27 Nov 2020 SH19 Statement of capital on 27 November 2020
  • GBP 1
27 Nov 2020 CAP-SS Solvency Statement dated 20/11/20
27 Nov 2020 RESOLUTIONS Resolutions
  • RES13 ‐ Reduce share prem a/c 20/11/2020
09 Oct 2020 CS01 Confirmation statement made on 6 October 2020 with updates
09 Oct 2020 PSC05 Change of details for Bellicum Pharmaceuticals, Inc. as a person with significant control on 6 October 2020
07 Oct 2020 PSC05 Change of details for Bellicum Pharmaceuticals Onc as a person with significant control on 6 October 2020
06 Oct 2020 PSC05 Change of details for Bellicum Pharmaceuticals Onc as a person with significant control on 6 October 2020
13 Mar 2020 TM02 Termination of appointment of Cooley Services Limited as a secretary on 12 March 2020